Remdesivir Big Pharma Failure- Only Helped Those On Oxygen, Finds Mortality Too High For Standalone Treatment

Posted by freedomforall 1 day, 3 hours ago to News
0 comments | Share | Flag

"According to a pivotal study published in the New England Journal of Medicine late on Friday, Remdesivir, which was authorized to treat Covid-19 in a group of 1063 adults and children (split into two groups, one receiving placebo instead of remdesivir) who need i) supplemental oxygen, ii) a ventilator or iii) extracorporeal membrane oxygenation (ECMO), only significantly helped those on supplemental oxygen.

Meanwhile, and explaining the 6pm release on a Friday, the study also found no marked benefit from remdesivir for those who were healthier and didn’t need oxygen or those who were sicker, requiring a ventilator or a heart-lung bypass machine."

Add Comment



  • Comment hidden. Undo